As represented in Figure 1, in a total of 316 ovarian cancers, BECN1 has been observed amplified in one patient and bearing a missense mutation in another patient (0.6%); BRCA1 mutated cases were observed in 38 patients (12%), and mutated TP53 was reported in as many as 303 patients (96%). This evidence concerns the gene BECN1 and ovarian carcinoma.